Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
The DOI matches its Crossref record.
Abstract
The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The management of patients with HCC has improved markedly since the first BCLC classification was proposed in 1999143.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [143]
Citations
Cites
Still being checked.
Cited by
Items 901–1,000 of 1,005
Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma
Schraiber, L. D. S., de Mattos, Â. A., Zanotelli, M. L., Cantisani, G. P. C., Brandão, A. B. D. M., Marroni, C. A., Kiss, G., Ernani, L., & Marcon, P. D. S. (2016) · Medicine · doi:10.1097/md.0000000000002478 · Cited by 45
Hiraoka, A., Kumada, T., Nouso, K., Tsuji, K., Itobayashi, E., Hirooka, M., Kariyama, K., Ishikawa, T., Tada, T., Toyoda, H., et al. (2016) · Oncology · doi:10.1159/000447061 · Cited by 45
Sanoff, H. K., Chang, Y., Reimers, M. A., & Lund, J. L. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.017814 · Cited by 45
Pinato, D. J., Yen, C., Bettinger, D., Ramaswami, R., Arizumi, T., Ward, C. E., Pirisi, M., Burlone, M. E., Thimme, R., Kudo, M., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13904 · Cited by 45
Jianyong, L., Zhong, J., Lunan, Y., Jingqiang, Z., Wentao, W., Yong, Z., Li, B., Tianfu, W., & Jiaying, Y. (2017) · Scientific Reports · doi:10.1038/srep41624 · Cited by 45
Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma
Ziogas, I. A., & Tsoulfas, G. (2017) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v9.i12.233 · Cited by 45
the HepatoCatt Study Group, Iezzi, R., Pompili, M., Rinninella, E., Annicchiarico, E. B., Garcovich, M., Cerrito, L., Ponziani, F. R., Gaetano, A. D., Siciliano, M., et al. (2018) · European Radiology · doi:10.1007/s00330-018-5692-8 · Cited by 45
Dakhoul, L., Gawrieh, S., Jones, K. R., Ghabril, M., McShane, C., Orman, E. S., Gómez, E. V., Chalasani, N., & Nephew, L. D. (2018) · Hepatology Communications · doi:10.1002/hep4.1277 · Cited by 45
Bloom, A., Bloom, S., Silva, H., Nicoll, A., & Sawhney, R. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100549 · Cited by 45
Impact of PIVKA-II in diagnosis of hepatocellular carcinoma
Zakhary, N. I., Khodeer, S., Shafik, H. E., & Malak, C. A. A. (2013) · Journal of Advanced Research · doi:10.1016/j.jare.2012.10.004 · Cited by 45
Nanashima, A., Sumida, Y., Abo, T., Shindou, H., Fukuoka, H., Takeshita, H., Hidaka, S., Tanaka, K., Sawai, T., Yasutake, T., et al. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-005-1751-4 · Cited by 45
Inaba, Y., Kanai, F., Aramaki, T., Yamamoto, T., Tanaka, T., Yamakado, K., Kaneko, S., Kudo, M., Imanaka, K., Kora, S., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.05.011 · Cited by 45
Dunne, R. M., Shyn, P. B., Sung, J. C., Tatlı, S., Morrison, P. R., Catalano, P. J., & Silverman, S. G. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.01.007 · Cited by 45
Hepatocellular carcinoma in hepatitis D: Does it differ from hepatitis B monoinfection?
Abbas, Z., Qureshi, M., Hamid, S. S., & Jafri, W. (2012) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.91731 · Cited by 45
Liang, L., Xing, H., Zhang, H., Zhong, J., Li, C., Lau, W. Y., Wu, M., Shen, F., & Yang, T. (2017) · HPB · doi:10.1016/j.hpb.2017.10.004 · Cited by 45
Takayasu, K. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys020 · Cited by 44
Lim, C., Osseis, M., Lahat, E., Doussot, A., Sotirov, D., Hémery, F., Minet, M. L., Féray, C., Salloum, C., & Azoulay, D. (2018) · Surgical Endoscopy · doi:10.1007/s00464-018-6347-1 · Cited by 44
The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
Obi, S., Sato, T., Sato, S., Kanda, M., Tokudome, Y., Kojima, Y., Suzuki, Y., Hosoda, K., Kawai, T., Kondo, Y., et al. (2019) · Hepatology International · doi:10.1007/s12072-019-09929-4 · Cited by 44
von Hessen, L., Roumet, M., Maurer, M. H., Lange, N. F., Reeves, H. L., Dufour, J., & Radu, P. (2020) · Liver International · doi:10.1111/liv.14755 · Cited by 44
Pacella, C. M., Bizzarri, G., Francica, G., Forlini, G., Petrolati, A., Valle, D., Anelli, V., Bianchini, A., Nuntis, S. D., Pacella, S., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.01.031 · Cited by 44
Perioperative Mortality for Management of Hepatic Neoplasm: A Simple Risk Score
Simons, J. P., Hill, J. S., Ng, S. C., Shah, S. A., Zhou, Z., Whalen, G. F., & Tseng, J. F. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bc9c2f · Cited by 44
Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma
Daniele, B., Annunziata, M., Barletta, E., Tinessa, V., & Maïo, M. D. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00186.x · Cited by 44
Kitai, S., Kudo, M., Minami, Y., Ueshima, K., Chung, H., Hagiwara, S., Inoue, T., Ishikawa, E., Takahashi, S., Asakuma, Y., et al. (2008) · Intervirology · doi:10.1159/000122599 · Cited by 44
Hou, J.-Z., Zeng, Z., Wang, B.-L., Yang, P., Zhang, J., & Mo, H.-F. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv205 · Cited by 44
A conceptual proposal for staging ductal cholangiocarcinoma
Blechacz, B. R. A., Sánchez, W., & Gores, G. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283292383 · Cited by 44
Recent advances in surgical treatment of hepatocellular carcinoma
Song, T. (2015) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2015.01051 · Cited by 43
Kim, D. Y., & Han, K. (2016) · Hepatology International · doi:10.1007/s12072-016-9722-9 · Cited by 43
Adhoute, X., Pénaranda, G., Raoul, J., Blanc, J. F., Edeline, J., Conroy, G., Perrier, H., Pol, B., Bayle, O., Monnet, O., et al. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000558 · Cited by 43
Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments
Adhoute, X., Pénaranda, G., Raoul, J., Treut, P. L., Bollon, E., Hardwigsen, J., Castellani, P., Perrier, H., & Bourlière, M. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i17.703 · Cited by 43
Choi, J. W., Kim, H., Lee, J., Yu, S. J., Kim, Y. J., Yoon, J., Jae, H. J., Hur, S., Lee, M., & Chung, J. W. (2016) · European Radiology · doi:10.1007/s00330-016-4511-3 · Cited by 43
Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
Cho, Y., Sinn, D. H., Yu, S. J., Gwak, G. Y., Kim, J. H., Yoo, Y. J., Jun, D. W., Kim, T. Y., Lee, H. Y., Cho, E. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165722 · Cited by 43
Fu, Y., Yi, Y., Huang, J., Jing, C., Sun, J., Ni, X., Lu, Z., Cao, Y., Zhou, J., Fan, J., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0231 · Cited by 43
Court, C. M., Harlander‐Locke, M. P., Markovic, D., French, S. W., Naini, B. V., Lu, D., Raman, S. S., Kaldas, F. M., Zarrinpar, A., Farmer, D. G., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24811 · Cited by 43
Ho, C. H. M., Chiang, C., Lee, F. A. S., Choi, C., Chan, J. C. H., Yeung, C. S. Y., Huang, J.-G., Chan, M. K. H., Blanck, O., & Wong, F. C. S. (2018) · Oncotarget · doi:10.18632/oncotarget.25522 · Cited by 43
Liu, W. Y., Zhou, J., Sun, Y., Zhang, L., & Xing, B. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2811-6 · Cited by 43
Matboli, M., Shafei, A., ALI, M. A. M., Ashry, A. M., Kamal, K. M., Agag, M. A., Reda, I., Tash, E. F., & Ali, M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28045 · Cited by 43
Dobrzycka, M., Spychalski, P., Rostkowska, O. M., Wilczyński, M., Kobiela, P., Grąt, M., Dell’Acqua, V., Høyer, M., & Jereczek-Fossa, B. A. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1657942 · Cited by 43
Ohki, T., Sato, K., Kondo, M., Goto, E., Sato, T., Kondo, Y., Akamatsu, M., Sato, S., Yoshida, H., Koike, Y., et al. (2020) · Drugs - Real World Outcomes · doi:10.1007/s40801-020-00179-7 · Cited by 43
Liu, F., Wang, H., Ma, W., Li, J., Liu, Y., Tang, S., Li, K., Jiang, P., Yang, Z., He, Y., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-022-13027-5 · Cited by 43
Surgical treatment of hepatocellular carcinoma
Hasegawa, K., & Kokudo, N. (2009) · Surgery Today · doi:10.1007/s00595-008-4024-z · Cited by 43
Carr, B. I., Pančoška, P., & Branch, R. A. (2009) · Hepatology International · doi:10.1007/s12072-009-9157-7 · Cited by 43
PET/CT Characteristics of Isolated Bone Metastases in Hepatocellular Carcinoma
Ho, C.-L., Chen, S., Cheng, T. K. C., & Leung, Y. L. (2010) · Radiology · doi:10.1148/radiol.10100672 · Cited by 43
Ji, S. K., Cho, Y. K., Ahn, Y. S., Kim, M. Y., Park, Y. O., Kim, T. Y., & Kim, W. (2008) · Korean Journal of Radiology · doi:10.3348/kjr.2008.9.6.534 · Cited by 43
Hou, W., Liu, J., Chen, P., Wang, H., Ye, B., & Qiang, F. (2014) · Oncology Letters · doi:10.3892/ol.2014.2253 · Cited by 44
Shiozawa, K., Watanabe, M., Ikehara, T., Matsukiyo, Y., Kogame, M., Kishimoto, Y., Okubo, Y., Makino, H., Tsukamoto, N., Igarashi, Y., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i48.13490 · Cited by 43
Nanashima, A., Sumida, Y., Morino, S., Yamaguchi, H., Tanaka, K., Shibasaki, S., Ide, N., Sawai, T., Yasutake, T., Nakagoe, T., et al. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.05.003 · Cited by 43
Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma
Johnson, P. J., Pinato, D. J., Kalyuzhnyy, A., & Toyoda, H. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02373 · Cited by 43
Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
Vu, N. B., Nguyen, T. T., Tran, L. C.-D., Do, C. D., Bắc, N. H., Phan, N. K., & Pham, P. V. (2012) · Cytotechnology · doi:10.1007/s10616-012-9511-9 · Cited by 42
Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI
Chapiro, J., Lin, M., Durán, R., Schernthaner, R. E., & Geschwind, J.-F. H. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.978861 · Cited by 42
Wang, T., Lu, X., Chi, J., Ding, M., Zhang, Y., Tang, X., Li, P., Zhang, L., Zhang, X., & Zhai, B. (2016) · Scientific Reports · doi:10.1038/srep32728 · Cited by 42
Hepatocellular carcinoma: Present and future
Armengol, C., Sarrias, M., & Sala, M. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.08.024 · Cited by 42
Kawaguchi, T., Tokushige, K., Hyogo, H., Aikata, H., Nakajima, T., Ono, M., Kawanaka, M., Sawada, K., Imajo, K., Honda, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28650-0 · Cited by 42
Kabir, T., Ye, M., Noor, N. A. M., Woon, W., Junnarkar, S. P., & Shelat, V. G. (2019) · International Journal of Hepatology · doi:10.1155/2019/4239463 · Cited by 42
Tai, Y., Zhang, L.-H., Gao, J.-H., Zhao, C., Tong, H., Cheng, Y., Huang, Z.-Y., Liu, R. R., & Tang, C.-W. (2019) · Cancer Management and Research · doi:10.2147/cmar.s183376 · Cited by 42
Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
Duan, J., Wu, Y., Liu, J., Zhang, J., Fu, Z., Feng, T., Liu, M., Han, J., Li, Z., & Chen, S. (2019) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s224849 · Cited by 42
Kim, D. H., Choi, S. H., Shim, J. H., Kim, S. Y., Lee, S. S., Byun, J. H., & Choi, J. (2021) · Cancers · doi:10.3390/cancers13122975 · Cited by 42
Müller, L., Hähn, F., Mähringer‐Kunz, A., Stoehr, F., Gairing, S. J., Foerster, F., Weinmann, A., Galle, P. R., Mittler, J., dos Santos, D. P., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.696183 · Cited by 42
Nadarević, T., Colli, A., Giljača, V., Fraquelli, M., Casazza, G., Manzotti, C., Štimac, D., & Miletić, D. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014798.pub2 · Cited by 42
Tsuchiya, K., Asahina, Y., Tamaki, N., Yasui, Y., Hosokawa, T., Ueda, K., Nakanishi, H., Itakura, J., Kurosaki, M., Enomoto, N., et al. (2013) · Liver Transplantation · doi:10.1002/lt.23798 · Cited by 42
Liese, J., Abhari, B. A., & Fulda, S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.018 · Cited by 42
Marelli, L., Shusang, V., Buscombe, J. R., Cholongitas, Ε., Stigliano, R., Davies, N., Tibballs, J. M., Patch, D., Meyer, T., & Burroughs, A. K. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060558 · Cited by 42
Disparities in Hepatocellular Carcinoma Survival among Californians of Asian Ancestry, 1988 to 2007
Kwong, S. L., STEWART, S. L., Aoki, C. A., & Chen, M. S. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0477 · Cited by 42
Sacco, R., Bertini, M., Petruzzi, P., Bertoni, M., Bargellini, I., Bresci, G., Federici, G., Gambardella, L., Metrangolo, S., Parisi, G., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1843 · Cited by 42
Sullivan, K. M., Groeschl, R. T., Turaga, K. K., Tsai, S., Christians, K. K., White, S. B., Rilling, W. S., Pilgrim, C. H. C., & Gamblin, T. C. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23448 · Cited by 42
Kao, W., Chao, Y., Chang, C., Li, C., Su, C., Huo, T., Huang, Y., Chang, Y., Lin, H., & Wu, J. (2015) · Medicine · doi:10.1097/md.0000000000001929 · Cited by 42
Zhu, Q., Qiao, G., Zeng, X.-C., Li, Y., Yan, J., Duan, R., & Du, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.10222 · Cited by 42
Chen, T. W., Chu, C. M.-Y., Yu, J. C., Chen, C. J., Chan, D., Liu, Y. C., & Hsieh, C. (2006) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2006.10.012 · Cited by 42
Technologies for Ablation of Hepatocellular Carcinoma
Callstrom, M. R., & Charboneau, J. W. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.022 · Cited by 42
Goel, A., Mehta, N. J., Guy, J. E., Fidelman, N. A., Yao, F. Y., Roberts, J. P., & Terrault, N. A. (2014) · Liver Transplantation · doi:10.1002/lt.23945 · Cited by 41
Zhao, Y., Cai, G., Zhou, L., Liu, L., Qi, X., Bai, M., Li, Y., Fan, D., & Han, G. (2013) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12081 · Cited by 41
Treatment of hepatocellular carcinoma in Child-Pugh B patients
Piscaglia, F., Terzi, E., Cucchetti, A., Trimarchi, C., Granito, A., Leoni, S., Marinelli, S., Pini, P., & Bolondi, L. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.03.002 · Cited by 41
Cox, I. J., Aliev, A. E., Crossey, M. M. E., Dawood, M., Al‐Mahtab, M., Akbar, S. M., Rahman, S., Riva, A., Williams, R. L., & Taylor-Robinson, S. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4191 · Cited by 41
Coppola, N., de Stefano, G., Panella, M., Onorato, L., Iodice, V., Minichini, C., Mosca, N., Desiato, L., Farella, N., Starace, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15809 · Cited by 41
Kloth, C., Thaiss, W. M., Kärgel, R., Grimmer, R., Fritz, J. M., Ioanoviciu, S. D., Ketelsen, D., Nikolaou, K., & Horger, M. (2017) · Academic Radiology · doi:10.1016/j.acra.2017.05.006 · Cited by 41
Value of quality of life analysis in liver cancer: A clinician’s perspective
Li, L., & Yeo, W. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i20.867 · Cited by 41
Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma
Shiba, S., Abe, T., Shibuya, K., Katoh, H., Koyama, Y., Shimada, H., Kakizaki, S., Shirabe, K., Kuwano, H., Ohno, T., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3724-4 · Cited by 41
Fang, A., Long, J., Zhang, Y., Liu, Z.-Y., Li, Q., Zhang, D., Luo, Y., Zhong, R., Zhou, Z., Xu, Y., et al. (2020) · Hepatology · doi:10.1002/hep.31013 · Cited by 42
Kaneko, S., Tsuchiya, K., Yasui, Y., Inada, K., Kirino, S., Yamashita, K., Osawa, L., Hayakawa, Y., Sekiguchi, S., Higuchi, M., et al. (2020) · Hepatology Research · doi:10.1111/hepr.13567 · Cited by 41
Bekki, Y., Martí, J. M., Toshima, T., Lewis, S. C., Kamath, A., Argiriadi, P. A., Simpson, W. L., Facciuto, L., Patel, R. S., Gunasekaran, G., et al. (2021) · Surgery · doi:10.1016/j.surg.2020.12.012 · Cited by 41
Vitale, A., Farinati, F., Finotti, M., Renzo, C. D., Brancaccio, G., Piscaglia, F., Cabibbo, G., Caturelli, E., Missale, G., Marra, F., et al. (2021) · Cancers · doi:10.3390/cancers13071673 · Cited by 41
Katariya, N., Lizaola‐Mayo, B., Chascsa, D. M. H., Giorgakis, E., Aqel, B. A., Moss, A. A., Usón, P. L. S., Borad, M. J., & Mathur, A. K. (2022) · Cancers · doi:10.3390/cancers14092056 · Cited by 41
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Vithayathil, M. K., D’Alessio, A., Fulgenzi, C. A. M., Nishida, N., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Saeed, A., Wietharn, B., et al. (2022) · Liver International · doi:10.1111/liv.15405 · Cited by 41
Pawlik, T. M., Esnaola, N. F., & Vauthey, J. (2004) · Liver Transplantation · doi:10.1002/lt.20052 · Cited by 41
Management of Hepatocellular Carcinoma
Asham, E. H., Kaseb, A. O., & Ghobrial, R. M. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.08.008 · Cited by 41
Pracht, M., Edeline, J., Lenoir, L., Latournerie, M., Mesbah, H., Audrain, O., Rolland, Y., Clément, B., Raoul, J., Garin, É., et al. (2013) · International Journal of Hepatology · doi:10.1155/2013/827649 · Cited by 41
Sorafenib for the treatment of advanced hepatocellular carcinoma
Connock, M. J., Round, J. A., Bayliss, S. E., Tubeuf, S., Greenheld, W., & Moore, D. (2010) · Health Technology Assessment · doi:10.3310/hta14suppl1-03 · Cited by 41
Gómez-Rodríguez, R., Romero-Gutiérrez, M., Artaza-Varasa, T., González-Frutos, C., Ciampi-Dopazo, J. J., Cruz-Pérez, G.-D.-L., & Sánchez‐Ruano, J. J. (2012) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082012000600003 · Cited by 41
Tribillon, E., Barbier, L. A., Goumard, C., Irtan, S., Perdigão, F., Durand, F., Paradis, V., Belghiti, J., Scatton, O., & Soubrane, O. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-3018-6 · Cited by 41
Screening for hepatocellular carcinoma
Sherman, M. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00180.x · Cited by 41
Selection of patients with hepatocellular carcinoma for liver transplantation
Sutcliffe, R. P., Maguire, D., Portmann, B. C., Rela, M., & Heaton, N. D. (2005) · British journal of surgery · doi:10.1002/bjs.5198 · Cited by 41
Santambrogio, R., Bruno, S., Kluger, M. D., Costa, M., Salceda, J., Belli, A., Laurent, A., Barabino, M., Opocher, E., Azoulay, D., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.11.010 · Cited by 40
Utility of Serum Neuropilin-1 and Angiopoietin-2 as Markers of Hepatocellular Carcinoma
Ghafar, M. T. A., Elkhouly, R. A., Elnaggar, M. H., Mabrouk, M. M., Darwish, S., Younis, R. L., & Elkholy, R. A. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001744 · Cited by 40
Kohi, M. P., Fidelman, N. A., Naeger, D. M., LaBerge, J. M., Gordon, R. L., & Kerlan, R. K. (2012) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2012.08.032 · Cited by 40
Manini, M. A., Sangiovanni, A., Martinetti, L., Viganò, D., Mura, V. L., Aghemo, A., Iavarone, M. A., Crespi, S., Nicolini, A., & Colombo, M. (2015) · Liver Transplantation · doi:10.1002/lt.24196 · Cited by 40
Zhu, X. M., Zhang, J., Fan, W., Wang, F., Yao, H., Wang, Z., Hou, S., Tian, Y., Fu, W., Xie, D., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt061 · Cited by 40
CT and MRI of hepatocellular carcinoma: an update
Ayyappan, A. P., & Jhaveri, K. S. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.24 · Cited by 40
Yan, X., Fu, X., Cai, C., Zi, X., Yao, H., & Qiu, Y. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000418 · Cited by 40
Ho, S., Liu, P., Hsu, C., Chiou, Y., Su, C., Lee, Y.-H., Huang, Y., Lee, F., Hou, M., & Huo, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-19251-y · Cited by 40
Radiotherapy for Hepatocellular Carcinoma
Yu, Y., & Feng, M. U.-S. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.06.005 · Cited by 40
An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective
Rim, C. H., Cheng, J. C., Huang, W.-Y., Kimura, T., Lee, V. H.-F., Zeng, Z., & Seong, J. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.03.027 · Cited by 40
Metadata
- Authors
- Llovet, J., Brú, C., & Bruix, J.
- Affiliations
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 19
- Issue
- 03
- Pages
- 329-338
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2147172608
- Cited by
- 3,805
- References
- 0
- Citations by year
- 2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.